UnitedHealth Defends Home-Health Diagnosis Coding as Medicare Advantage Scrutiny Continues

What UnitedHealth's new disclosure changed

UnitedHealth Group has said that the large majority of diagnoses recorded during home-health visits in 2025 were medically supported, a direct response to years of scrutiny over how the company documents patient conditions for its Medicare Advantage plans. Home-based health assessments have become a flashpoint in this industry because the diagnoses recorded during these visits feed into the risk scores insurers use to justify higher payments for sicker patients. Regulators, journalists, and short sellers have questioned whether some of that coding overstates how sick patients actually are, and UnitedHealth has faced more of this scrutiny than most peers given its size in Medicare Advantage.

Why it matters for managed-care and health-insurer stocks

Medicare Advantage risk-adjustment revenue is central to UnitedHealth's business model through its UnitedHealthcare and Optum units, so any credible defense of its coding practices matters directly to the company's regulatory and legal risk profile. A disclosure showing most diagnoses were supported does not end the broader scrutiny. Government investigations into Medicare Advantage billing practices, including UnitedHealth's, remain ongoing regardless of this specific figure. Still, it gives the company a concrete data point to push back on the narrative that home visits are used mainly to inflate risk scores rather than to genuinely assess patients, which matters for how investors and regulators weigh the company's long-term legal exposure.

Which stocks, and why

The story is squarely about UnitedHealth Group, the country's largest health insurer by revenue and the company that has drawn the most attention over Medicare Advantage coding practices. This disclosure is a defensive move in an ongoing regulatory and reputational dispute rather than a new financial figure, so the read is modestly positive for the company's near-term legal and regulatory standing without changing its underlying earnings. It does not extend cleanly to other managed-care names, since none of them were named in this specific disclosure and the coding scrutiny in this story has centered on UnitedHealth as the largest player in the space.

What to watch

The key follow-through will be whether federal investigators and the Centers for Medicare and Medicaid Services treat this kind of internal review as meaningful, or whether litigation and further audits continue regardless of the company's own findings. Watch for any formal updates from the ongoing government inquiries into Medicare Advantage billing, CMS risk-adjustment audit results, and whether UnitedHealth discloses similar figures for other parts of its home-health and in-home assessment programs in future filings or earnings calls.